Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens.
about
Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology GroupEvaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation.Long-term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study.Ototoxicity monitoring in children treated with platinum chemotherapy.Cisplatin is retained in the cochlea indefinitely following chemotherapy.Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.Monitoring neonates for ototoxicity.Ototoxicity: A Challenge in Diagnosis and Treatment.Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.
P2860
Q33922193-7E78304C-987A-47C3-B059-5569872EC494Q34401647-958FAC36-B610-41F5-A5F2-B37694F0DD01Q35069288-21494AD6-2A18-4401-9778-FFCBE54C9A16Q35197338-CE77E628-9AF9-4A43-A1C0-F8C9AA559D2CQ37431113-CA10CA09-A680-48A5-AE0E-147613E3F587Q39369556-FB2F7DB9-4D25-47D2-AC3E-FDBE0C466837Q39453840-4FF3AA94-1C34-4071-87CB-0C20F8BE3F26Q46002451-47BCD9C6-F878-4126-99F4-B2E1D589EAE9Q47702952-0EE3D6E9-14CA-46EF-AEBC-E638CD38D060Q48287747-7FF8EF42-EAB9-4E66-A333-8F2590DBE29EQ50300972-D87E08B4-A5BB-4393-9F2A-B88CB1EB3861Q50425568-1A555B9F-2AC0-4C8A-9668-5E2E98AE5D16Q50433278-1C9F5E84-0DA3-479D-9B3E-03534356C9CF
P2860
Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@en
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@nl
type
label
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@en
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@nl
prefLabel
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@en
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@nl
P2093
P1476
Late onset hearing loss: a sig ...... taining chemotherapy regimens.
@en
P2093
Daniel C Kolinsky
Jingnan Mao
Roanne Karzon
Robert J Hayashi
Susan S Hayashi
P304
P356
10.1097/MPH.0B013E3181CB8593
P577
2010-03-01T00:00:00Z